Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy

J Control Release. 2021 Nov 10:339:14-26. doi: 10.1016/j.jconrel.2021.09.019. Epub 2021 Sep 20.

Abstract

Ferroptosis is a type of programmed cell death caused by the iron-dependent lipid hydroperoxide pathway and has attracted significant interest. However, Fenton reaction-dependent ferroptosis has shown unsatisfactory therapeutic effects in tumor therapy, mainly due to inadequate reaction conditions in the tumor microenvironment. Here, we report a new strategy for Fenton-independent pathway by employing photothermal nanozyme to overcome limitations of the low efficiency of Fenton reaction. Specifically, we used iron redox pair (Fe2+/Fe3+)-containing hollow mesoporous Prussian blue (HMPB) nanocubes as the iron sources to fabricate iron-loaded liposome (HMPB@Lip). HMPB@Lip not only exerts the photothermal therapy, but also functions as nanozyme catalyzing lipid peroxidation for ferroptosis therapy. Importantly, Fenton reaction-independent ferroptosis triggered by photothermal nanozyme achieved effective tumor ablation. Therefore, HMPB@Lip can be used as a potential multifunctional nanozyme for effective Fenton reaction-independent ferroptosis therapy.

Keywords: Fenton reaction; Ferroptosis; Nanozyme; Photothermal therapy; Prussian blue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Breast Neoplasms* / drug therapy
  • Female
  • Ferroptosis*
  • Humans
  • Hydrogen Peroxide
  • Iron
  • Tumor Microenvironment

Substances

  • Hydrogen Peroxide
  • Iron